A migraine that keeps coming back after medication trials, specialist visits and years of disruption forces a brutal question; what’s left? We sit down with Dr. Rami Fakih, a Neuroendovascular Surgeon at Centra, to talk about an emerging, highly targeted option being explored for chronic refractory migraine and why it’s drawing serious attention in vascular neurology. We walk through what “chronic migraine” means clinically, how doctors define treatment-resistant or refractory migraine, and why accurate diagnosis matters before anyone considers a procedure. Dr. Fakih explains the basics of a catheter-based approach that navigates to the middle meningeal artery (MMA) and delivers lidocaine, a familiar medication used in many settings, with the goal of interrupting severe migraine patterns for a small group of carefully selected patients. We also talk about what early case reports and case series that suggest some patients feel improvement within hours, and others may experience symptom-free days, weeks, or even months. Because this is neuroendovascular surgery, we don’t gloss over the reality that “minimally invasive” still means invasive. We discuss risks, why repeat treatments aren’t automatic and why the best path forward is thoughtful referrals through headache specialists, stronger clinical evidence and randomized controlled trials that can clarify who benefits most and how long effects can last. If you’re a provider looking for options for refractory migraine, or a patient searching for credible hope without hype, this conversation is for you. Subscribe for more practical clinical conversations, share this with someone navigating chronic migraine, and leave a review with your biggest question so we can cover what you want next. For more content from Centra Health check us out on the following channels. YouTube Facebook Instagram Twitter
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
Cami SmithHi and welcome on and so much more. My name is Cami Smith, and I am your host. And I am here with Dr. Rami Fakih, who is a neuroendovascular surgeon here at Centra. Thank you for coming on with us. Um there is some recent research, some recent content that you're gonna speak to and kind of help us understand and wrap our brains around a little bit. But before we do that, tell us a little bit about yourself.
Dr. Rami FakihSure. So uh yeah, I'm uh, as you mentioned, neuroendovascular surgeon at Centra. I started over a year ago, and uh my background is in neurology, vascular neurology, and interventional neurology or neuroendovascular surgery, different ways to uh name the same thing. And um yeah, we do uh kind of a gamut of uh, as I say, minimally invasive procedures to the neck and the brain, uh, mainly at the vessels to treat a variety of uh vascular diseases in this region.
Cami SmithOkay.
Dr. Rami FakihAmong them is, you know, this new research that's been ongoing for the past couple of years of how to use this intervention for treatment of something maybe rather new in this neurovascular world, which is chronic migraines.
Cami SmithOkay.
Dr. Rami FakihAnd how we can add to the tool of treatment for this uh chronic condition that's quite common.
Cami SmithOkay. So this is, I think the way that it's listed on here is treatment-resistant migraines. And so these people who become your patients, this is very specialized. They have tried probably everything else at this point. So, what makes this particular type of migraine, if that's even what it is, what makes it so challenging to treat?
Dr. Rami FakihQuite on point, as you mentioned, because migraine in general is very common in the population of millions and millions of people uh who most commonly have what we call episodic migraine, right? You have a migraine once a week, twice a week, every once in a while. Everybody almost has that. Now, when we talk about chronic migraine, this is when it becomes like really a chronic thing. Uh loosely defined as more than eight migraines per month over at least three months.
Dr. Rami FakihAnd that's about maybe 10% of overall migraine patients. And within these chronic migraineurs, we have patients who are, as you mentioned, resistant to treatment, or as we call it refractory migraine. Uh, these are the people who, despite being on treatment, on several treatments, different trials, despite standard therapy, after a couple of months and even years, they still have these episodes. And uh it is disturbing to their lives, and this is where we can come in and help with that, with this intervention.
Cami SmithSo, what does this intervention look like?
Dr. Rami FakihUh basically catheter-based.
Cami SmithOkay.
Dr. Rami FakihSo using catheters, we go inside these vessels in the brain and uh we do our interventions. In this case, what we intervene on is this vessel called middle manager artery. Uh, the short is MMA.
Cami SmithOkay.
Dr. Rami FakihAnd we select, we go inside this vessel and we inject this uh drug basically, which is lidocaine. Um, and uh this is how the treatment is supposed to work with this medication acting on this area that is supplied by this artery. And this is how uh we can help certain patients who have this type of uh condition.
Cami SmithSo, in this research and this study that you were doing, you were setting out to determine if this particular approach was going to treat this particular type of migraine. So, what I mean, obviously it sounds like it does, but what does that mean now for patients and what does that mean now for your approach across the board?
Dr. Rami FakihYeah, so uh I want to stress that this is still kind of in its early stages. Um basically, it was my mentor who started this and tried it about 10 years ago. Okay, whom I trained with Dr. Gureshi. Uh, he really was, I believe, the first one who said, you know, based on pathophysiology of migraines, the menal benageologically seems to be involved. And then we have this medication that we've been using for decades, probably longer, which is lidocaine. Uh, we've been using it through the IV.
Dr. Rami FakihUm and uh he tried it and he saw that some of these patients actually had their migraine cured, at least in the short term.
Cami SmithYeah.
Dr. Rami FakihAnd he published the first case reports, and then since then there was a multiple case series uh amongst uh amongst which our case series, which was published last year when I was training in at the University of Missouri with Dr. Kureshi. And uh, we did find that yes, by doing this, by injecting lidocaine uh in certain very select patients, basically they had this uh refractory migraine treated, and some of them even lasted for weeks up to a couple of months.
Cami SmithOkay.
Dr. Rami FakihSo this is uh you know our hope that moving forward we have more people doing this and we have more case series, more patients to study, and then uh to really see how effective this procedure can be.
Cami SmithSo that's fascinating, first of all. So these people are finally getting relief um for something that it feels so small, like this injection into this very specific place. And so you mentioned something about like short term short-term relief when he did his study first. What is the like what is considered short-term relief? Is that like a few weeks? Is that a few months?
Dr. Rami FakihYeah, good question. I would say uh for these chronic uh migrineurs who have had this for a long, long time, they really see a benefit uh when this whole thing stops really within hours after the injection. And that by itself, I think is a really good uh success, uh, a good win. Now, having said that, a lot of these patients see that they're still symptom-free days after, weeks after, and some of them even months after.
Dr. Rami FakihUm, so I hope I answered your question.
Cami SmithYeah, well, it that it does, it is lasting so much longer. Um, are you like what is causing for some people it it may be days or weeks, but um, what do you see the future of this for those who need that long-lasting? Is this going to be like multiple treatments over time, or is this something that could eventually maybe lead to um something that is a true cure long term for people with migraines?
Dr. Rami FakihGreat question, great question. So, as I mentioned, we're still kind of in the early stages of studying this and having like these case series published. I think um the main uh goal would be to stop these refractory migraines. Some of them are really daily, ongoing uh kind of migraines, like uh status migrinosis, um, which means that the migraine, when it comes, it just stays there for hours and even days.
Dr. Rami FakihThat we can break that. So there's benefit in doing that. And then there is also benefit for these patients that have seen relief for months, yeah, that they can use that relief to go back to their normal selves, feel normal again, go back to work, and then see what they can change uh kind of in anticipation for their next uh migraine when it comes back.
Cami SmithYeah.
Dr. Rami FakihWe're not there yet to say if this procedure is something that we can do long term, because it is at the end of the day an invasive procedure. Okay, I have to stress that that we go inside the brain or near the brain, and uh there's all the inherent risks that come with this uh procedure. So I don't think it's something we will do like all the time for patients, uh at least not for now. Things don't always change. But it's good to do it the first time, maybe a second time, and see how that changes the patient life, really.
Dr. Rami FakihYeah, and kind of take it from there.
Cami SmithOkay. So, where does the research go from here? You said that it's still in the early stages, you want to see these long-term effects for these uh patients of yours. Um what does that look like from a study and a research standpoint?
Dr. Rami FakihYeah, so uh besides the case series, as in people just doing these cases and lumping them together, and then we talk with each other, and then we see as a whole group, maybe we have hundred plus patients, and then we study these patients. There are uh clinical trials that I believe have started. Some people have started doing that, like a formal randomized controlled trials using lidocaine versus uh nothing, and then seeing what's the difference. Uh, so this is kind of where the the field is going at.
Dr. Rami FakihAnd then there's also still uh benchmark, like uh bench um uh lab research that can be done regarding what uh material to inject beside lidocaine, maybe something that can last longer, perhaps. Uh so it's it's quite an interesting field, uh, and a lot a lot of uh uh uh you know, like a tabula rasa that's very open to new things, new ideas, new trials. Uh so that's where the excitement is.
Cami SmithYeah. So uh we have obviously numerous patients who deal with this on a regular basis and are probably listening to this and like getting their hopes up, getting excited, like, oh my gosh, is there relief? What is the patient journey? Obviously, like we talked about earlier, like this is when nothing else has worked. So, what leads them to you and then what does that patient journey look like?
Dr. Rami FakihGreat question, great question. So, in general, these are patients who I hope have maybe a headache specialist that has been following them.
Cami SmithOkay.
Dr. Rami FakihUh, I would say a neurologist or even a specialist within neurology that mostly take care of patients with headaches. Gotcha. Headache is really a big field, different types of headaches. Um, so ideally, these are the patients that have been seen a headache specialist, and then by definition, they they fall within the category of chronic refractory migraines. Well, they've tried multiple uh standard uh treatments, um, and then they still have these episodes.
Dr. Rami FakihI also want to stress that given that we have different types of headaches, I think our focus should remain at least now on uh the standard definition of migraines.
Cami SmithYeah.
Dr. Rami FakihAnd uh because at least now these are the type of headache that seems that this procedure can help with.
Cami SmithYeah.
Dr. Rami FakihUh contrary to other types of headaches with a different pathophysiology, which we're not sure yet that this can help them. So uh in general, I would say the ideal situation is that we get referrals from these headache specialists for these select patients, and then we evaluate them, we talk with them, and we take it from them.
Cami SmithOkay. So I think it's very important as this content is going out there, like this is a referral-based situation. Um, and so what does that look like to help inform other physicians when they do have a patient that this is such a great solution for how does that work?
Dr. Rami FakihYeah, so what we're doing this is one thing that can help podcast, getting our word out there, uh the research, um, meeting with people, uh even you know, when we share the same workroom, tell them about what we're doing and how we can help. Um, so education, educating uh what this new research for the physicians, for the providers. Uh I think that's one way to do that.
Cami SmithSo it's very physician-to-physician, provider-to-provider type of conversation, just getting that word out, helping to spread the so spread the word. This this is a solution for our patients. Um, and I think it is pretty incredible for those who have been in these debilitating situations and thought this is just life now. Like to hear that there's an option that can make such a big difference.
Dr. Rami FakihThat's true, that's true. And I'm glad that uh really the people uh before us have started this, have turned on the engine, and uh nowadays it's a really uh a hot topic, if you want. There's people all around the world kind of uh wanting wanting to dip into this uh this field because of how many patients really uh we can help uh with migraine being uh such a common uh condition.
Cami SmithSo you mentioned that this study is ongoing, this research is ongoing, and particularly maybe even using different types of medicine outside of lidocaine. So, how can these like referring physicians and providers, how do they know when those advancements or solutions have been found or made? How do they kind of stay in that?
Dr. Rami FakihYeah, well, of course, it takes uh you know somebody who wants to follow up on the latest research regarding this field. Um, you know, uh there's new papers, new research coming every week.
Cami SmithYeah.
Dr. Rami FakihUh but I would say from a provider perspective, perhaps knowing that this is an option and knowing who the people that are doing this are, you know, they can just refer these patients to us and kind of, you know, we we kind of we can we can take it from there, basically.
Cami SmithYeah, very cool.
Dr. Rami FakihYeah.
Cami SmithUm, is there anything I haven't asked you that you feel is important to include that either uh a listening physician or provider would know, or a patient who is kind of leaning in a little bit further right now because they're like, that's me.
Dr. Rami FakihYeah, I know. I mean, you thank you, first of all. Uh you really asked uh great questions. Uh you really uh hit the nail on the head. Um, I think we talked about what the procedure is, who are kind of the patients who might benefit from it, how the yeah, like how the procedure how the procedure goes. Um I think the next step would be perhaps to you know putting this word out there and see uh how uh the reaction is, if you want, or uh how the reception is.
Cami SmithYeah.
Dr. Rami FakihAnd uh we'll take it from there. It's still in its early stages, too. So we're also learning all the way.
Cami SmithYeah, so there's more to come. That's exciting. So for those of you who are listening, uh, we are going to be having lots of information on our website. Um, so you can learn more, you can lean in and kind of see um what is next for this particular type of research, as well as the actual piece of research itself. So you guys can find that. We'll drop that in the description. So thank you for joining me. Appreciate your time, and thank you guys for listening on in so much more.
AI in healthcare can feel like a black box, so we slow it down and talk about what’s actually changing at the bedside and what isn’t. I’m joined by Centra’s chief physician executive, Chris Thompson, to unpack how...
A faint red streak. No obvious lump. Just a deep sense that something wasn’t right. Ann Riley followed that instinct, kept calling for an opening, and pushed for answers until imaging revealed a breast cancer diagnosis...
AI in healthcare can help you find care faster, reduce friction at check-in, and give clinicians more time to actually talk with you. We’re joined by Sanjeev Sah, Centra Health’s Senior Vice President and Chief Digital...
A clearer heart scan can change more than an image, it can change a decision. We talk with Jared Vest, who oversees nuclear cardiology and PET CT at Centra, about the arrival of cardiac PET CT and why it’s a major leap...
A stiff back and aching leg can look like a simple lower spine problem until the real culprit hides higher up. We share Diane’s journey from conservative care to targeted injections and, finally, two precisely timed...